Harold S Minkowitz
Overview
Explore the profile of Harold S Minkowitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
781
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shafer S, Teichman S, Gottlieb I, Singla N, Minkowitz H, Leiman D, et al.
Anesthesiology
. 2024 Apr;
141(2):250-261.
PMID: 38662910
Background: Nonopioid management of postsurgical pain remains a major unmet need. Few studies have evaluated transient receptor potential vanilloid subfamily member 1 agonists for analgesia after surgery. This study examines...
2.
Beaton A, Solanki D, Salazar H, Folkerth S, Singla N, Minkowitz H, et al.
Reg Anesth Pain Med
. 2023 Apr;
48(12):601-607.
PMID: 37076252
Introduction: Surgical site infiltration with bupivacaine hydrochloride (HCl) is a standard element of postoperative analgesia for soft tissue surgeries, but results in short-lived analgesia. A novel bupivacaine implant, XARACOLL (bupivacaine...
3.
Winthrop K, Skolnick A, Rafiq A, Beegle S, Suszanski J, Koehne G, et al.
Open Forum Infect Dis
. 2022 Jul;
9(7):ofac232.
PMID: 35832268
Background: Opaganib, an oral sphingosine kinase-2 inhibitor with antiviral and anti-inflammatory properties, was shown to inhibit severe acute respiratory syndrome coronavirus 2 replication in vitro. We thus considered that opaganib...
4.
Jin Z, Gan T, Belani K, Bergese S, Chung F, Diemunsch P, et al.
Anesth Analg
. 2021 Jan;
132(2):e31-e33.
PMID: 33449569
No abstract available.
5.
Leiman D, Niebler G, Minkowitz H
Adv Ther
. 2020 Nov;
38(1):691-706.
PMID: 33237534
Introduction: Surgical site infiltration with bupivacaine HCl results in short-lived analgesia for postsurgical pain and carries the risk of systemic bupivacaine toxicity due to accidental intravascular injection. INL-001 is a...
6.
Gan T, Belani K, Bergese S, Chung F, Diemunsch P, Habib A, et al.
Anesth Analg
. 2020 May;
131(2):411-448.
PMID: 32467512
This consensus statement presents a comprehensive and evidence-based set of guidelines for the care of postoperative nausea and vomiting (PONV) in both adult and pediatric populations. The guidelines are established...
7.
Bergese S, Brzezinski M, Hammer G, Beard T, Pan P, Mace S, et al.
J Pain Res
. 2019 Dec;
12:3113-3126.
PMID: 31814753
Background: Pain management with conventional opioids can be challenging due to dose-limiting adverse events (AEs), some of which may be related to the simultaneous activation of β-arrestin (a signaling pathway...
8.
Candiotti K, Kranke P, Bergese S, Melson T, Motsch J, Siddiqui N, et al.
Anesth Analg
. 2019 May;
128(6):1098-1105.
PMID: 31094774
Background: Postoperative nausea and vomiting (PONV) occurs commonly in surgical patients despite widespread prophylactic antiemetic use. Rescue options are currently limited. 5HT3 antagonists are most frequently used for prophylaxis, but...
9.
Miner J, Melson T, Leiman D, Minkowitz H, Chiang Y, DiDonato K, et al.
Pain Manag
. 2019 Jan;
9(3):259-271.
PMID: 30614379
To evaluate the pooled safety of sufentanil sublingual tablets (SSTs) administered at 30-mcg dose equivalents over ≤72 h for moderate-to-severe acute pain management in medically supervised settings. Safety data from...
10.
Velanovich V, Rider P, Deck K, Minkowitz H, Leiman D, Jones N, et al.
Adv Ther
. 2018 Nov;
36(1):200-216.
PMID: 30467808
Introduction: Surgical site infiltration with bupivacaine results in short-lived analgesia. The MATRIX-1 and MATRIX-2 studies examined the efficacy and safety of the bioresorbable bupivacaine HCl collagen-matrix implant (INL-001) for postsurgical...